These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3137416)

  • 21. Evaluation of the metabolizing capacity of S9 liver preparations from rats and mice using a test with Salmonella typhimurium TA100.
    Gajcy H; Pieńkowska K; Koziorowska J; Czarnomska A
    Pol J Pharmacol Pharm; 1987; 39(1):27-32. PubMed ID: 3313326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutagenicity spectra in Salmonella typhimurium strains of glutathione, L-cysteine and active oxygen species.
    Glatt H
    Mutagenesis; 1989 May; 4(3):221-7. PubMed ID: 2543888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conditions for the optimal use of the L-arabinose-resistance mutagenesis test with Salmonella typhimurium.
    Hera C; Pueyo C
    Mutagenesis; 1986 Jul; 1(4):267-73. PubMed ID: 3331667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of a comparative study on the Salmonella pre-incubation and plate incorporation assays using test samples from the IPCS collaborative study.
    Goto S; Endo O; Matsushita H
    Mutat Res; 1992; 276(1-2):93-100. PubMed ID: 1370112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling the Ames Salmonella/microsome assay.
    Krewski D; Leroux BG; Bleuer SR; Broekhoven LH
    Biometrics; 1993 Jun; 49(2):499-510. PubMed ID: 8369384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic activation of 3-nitroperylene in the Salmonella/S9 assay.
    Anderson JG; McCalla DR; Bryant DW; McCarry BE; Bromke AM
    Mutagenesis; 1987 Jul; 2(4):279-85. PubMed ID: 3325759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative mutagenicity studies of azo dyes and their reduction products in Salmonella typhimurium.
    Krishna G; Xu J; Nath J
    J Toxicol Environ Health; 1986; 18(1):111-9. PubMed ID: 3517355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimutagenic and anticlastogenic effects of Turkish Black Tea on TA98 and TA100 strains of Salmonella typhimurium (in vitro) and mice (in vivo).
    Charehsaz M; Sipahi H; Giri AK; Aydin A
    Pharm Biol; 2017 Dec; 55(1):1202-1206. PubMed ID: 28245735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of mutagenicities of N-nitrosamines on Salmonella typhimurium TA100 and Escherichia coli WP2 uvrA/pKM101 using rat and hamster liver s9.
    Araki A; Muramatsu M; Matsushima T
    Gan; 1984 Jan; 75(1):8-16. PubMed ID: 6373472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mutagenicity of mixtures of halogenated aliphatic hydrocarbons and polycyclic aromatic hydrocarbons in the Ames test with TA98 and TA100].
    Kevekordes S; Porzig J; Gebel T; Dunkelberg H
    Zentralbl Hyg Umweltmed; 1998 Feb; 200(5-6):531-41. PubMed ID: 9531725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial genotoxicity of nitrosated famotidine.
    De Flora S; Camoirano A; Basso C; Astengo M; Zanacchi P; Bennicelli C
    Mutagenesis; 1986 Mar; 1(2):125-30. PubMed ID: 2905760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation and detoxification of 1,8-dinitropyrene by mammalian hepatic fractions in the Salmonella mutagenicity assay.
    Shah AB; Combes RD; Rowland IR
    Mutagenesis; 1990 Jan; 5(1):45-9. PubMed ID: 2184311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assay of phenacetin genotoxicity using in vitro and in vivo test systems.
    De Flora S; Russo P; Pala M; Fassina G; Zunino A; Bennicelli C; Zanacchi P; Camoirano A; Parodi S
    J Toxicol Environ Health; 1985; 16(3-4):355-77. PubMed ID: 3910846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative mutagenicity of dimethylaminoazobenzene and analogues in Salmonella.
    Zeiger E; Pagano DA
    Carcinogenesis; 1982; 3(5):559-61. PubMed ID: 6807565
    [No Abstract]   [Full Text] [Related]  

  • 35. Mutagenicity of 2-alkyl-N-nitrosothiazolidines.
    Sekizawa J; Shibamoto T
    J Agric Food Chem; 1980; 28(4):781-3. PubMed ID: 7007465
    [No Abstract]   [Full Text] [Related]  

  • 36. The disposition and in vivo covalent binding to liver DNA of the monoazodyes 6-(p-dimethylaminophenylazo)benzothiazole (6BT) and 5-(p-dimethylaminophenylazo)indazole (5I) after administration to the rat.
    Dashwood RH; Combes RD; Ashby J
    Carcinogenesis; 1986 Jun; 7(6):1029-33. PubMed ID: 3085965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An improvement of the Ames test using a modified human liver S9 preparation.
    Hakura A; Suzuki S; Sawada S; Motooka S; Satoh T
    J Pharmacol Toxicol Methods; 2001; 46(3):169-72. PubMed ID: 12183193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors affecting the response of N,N-dimethylaminoazobenzene in the Ames microbial mutation assay.
    Robertson J; Harris WJ; McGregor DB
    Carcinogenesis; 1982; 3(9):977-80. PubMed ID: 6814779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of pro-mutagens in complex mixtures by rat liver S9 systems.
    Courtois YA; Pesle ML; Festy B
    Mutat Res; 1992; 276(1-2):133-7. PubMed ID: 1370104
    [No Abstract]   [Full Text] [Related]  

  • 40. Azoreductase activity of Sprague Dawley and Wistar-derived rats towards both carcinogenic and non-carcinogenic analogues of 4-dimethylaminophenylazobenzene (DAB).
    Elliott BM
    Carcinogenesis; 1984 Aug; 5(8):1051-5. PubMed ID: 6430584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.